Starling Oncology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $164.7M
Liabilities Breakdown FY2025
Total Liabilities: $180.4M
Asset Breakdown
Total Assets: $164.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $33.6M | 20.4% |
| Accounts Receivable | $59.0M | 35.8% |
| Inventory | $16.9M | 10.2% |
| Property, Plant & Equipment | $10.7M | 6.5% |
| Goodwill | $7.2M | 4.4% |
| Intangible Assets | $11.0M | 6.7% |
| Other Assets | $26.3M | 16.0% |
Liabilities Breakdown
Total Liabilities: $180.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $43.2M | 23.9% |
| Long-Term Debt | $77.4M | 42.9% |
| Other Liabilities | $59.8M | 33.2% |